AG
JAZZ icon

Algert Global’s Jazz Pharmaceuticals JAZZ Stock Holding History

Algert Global’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
48,760
-3,760
-7% -$824K 0.14% 219
2026
Q1 		$9.93M Hold
52,520
– – 0.15% 206
2025
Q4 		$8.93M Buy
+52,520
New +$8.05M 0.14% 247
2025
Q1 		– Sell
-13,655
Closed -$1.68M – 1259
2024
Q4 		$1.68M Buy
+13,655
New +$1.61M 0.04% 664
2024
Q3 		– Sell
-5,964
Closed -$637K – 1376
2024
Q2 		$637K Buy
+5,964
New +$656K 0.02% 818
2023
Q2 		– Sell
-8,959
Closed -$1.31M – 1166
2023
Q1 		$1.31M Buy
+8,959
New +$1.33M 0.06% 521
2020
Q4 		– Sell
-23,218
Closed -$3.31M – 449
2020
Q3 		$3.31M Buy
+23,218
New +$2.88M 1.05% 5
2016
Q4 		– Sell
-9,108
Closed -$1.11M – 373
2016
Q3 		$1.11M Buy
9,108
+7,397
+432% +$997K 0.32% 124
2016
Q2 		$242K Sell
1,711
-7,873
-82% -$1.16M 0.1% 297
2016
Q1 		$1.25M Buy
9,584
+1,254
+15% +$156K 0.47% 59
2015
Q4 		$1.17M Buy
+8,330
New +$1.15M 0.55% 52

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Algert Global's JAZZ Position: Q2 2026 in Review

Algert Global reduced its Jazz Pharmaceuticals (JAZZ) stake by 7.2% in Q2 2026, selling an estimated $824K and leaving 48,760 shares worth $11.7M. The position accounts for 0.14% of the portfolio, ranked #219.

Algert Global first reported a position in JAZZ in Q4 2015 and has held it in 11 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Algert Global held 48,760 shares of Jazz Pharmaceuticals worth $11.7M as of Q2 2026.
  • Algert Global sold 3,760 Jazz Pharmaceuticals shares in Q2 2026, an estimated $824K.
  • Jazz Pharmaceuticals made up 0.14% of Algert Global's portfolio in Q2 2026, its #219 holding.
  • Algert Global first reported a position in Jazz Pharmaceuticals in Q4 2015 and has held it in 11 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.